Peter Valent

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Wolfgang R. Sperr

AUSTRIA

View details

Thomas Rülicke

University of Veterinary Medicine Vienna

AUSTRIA

View details

Mencía Ruiz Gutiérrez-Colosía

Profesora titular

Universidad Loyola Andalucía

SPAIN

View details

Daniel Royston

Associate Professor

University of Oxford

UNITED KINGDOM

View details

Nicholas Cross

Professor of Human Genetics

University of Southampton

UNITED KINGDOM

View details

Florence Roufosse

Université libre de Bruxelles

BELGIUM

View details

Johannes Lübke

Heidelberg University

GERMANY

View details

Ashwin Kishtagari

Assistant Professor of Medicine

Vanderbilt University Medical Center

UNITED STATES

View details

Elisabeth Zeilinger

Universität Wien

AUSTRIA

View details

Theo Gülen

SWEDEN

View details

Karin Bauer

Medical University of Vienna

AUSTRIA

View details

Philipp Staber

Associate Professor; Director Lymphoma and CLL program

Medical University of Vienna

AUSTRIA

View details

Berend Snijder

Assistant Professor

ETH Zürich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Valent

Research Interests

Explore related searches

Contact this professor

Articles (10)

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.

Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine.

Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes

Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population

Cancer – A devastating disease, but also an eye-opener and window into the deep mysteries of life and its origins

MPN-435 Overall Survival in Patients With Systemic Mastocytosis With Associated Hematologic Neoplasm Treated With Avapritinib Versus Best Available Therapy

Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies

Mast Cell Leukemia: Clinical and Molecular Features and Survival Outcomes of Patients in the ECNM Registry

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia

Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatients

Collaborators (13)

Wolfgang R. Sperr

Thomas Rülicke

Mencía Ruiz Gutiérrez-Colosía

Daniel Royston

Nicholas Cross

Florence Roufosse

Johannes Lübke

Ashwin Kishtagari

Elisabeth Zeilinger

Theo Gülen

Karin Bauer

Philipp Staber

Berend Snijder

Make your next move.